Overall, these findings suggest that USF2 regulated the expression of oncogenic metabolic hubs in bladder cancer via NuRD-complex driven histone deacetylation, and its downregulation leads to aggressive disease state and poor survival in bladder cancer patients. The gene discussed is USF2; the disease is urinary bladder carcinoma.